Recent business results
Our company representative, Mr. Ogami, served as a management leader at Topcon Corporation and successfully revitalized the company, which had a long history.
- In 2017, he became an advisor to the weekly management strategy meeting, where he provided various recommendations and practical support, acting as an engine for corporate reform.
- In 2018, he was appointed Managing Executive Officer and General Manager of the Eye Care Business Division, which manufactures and sells eye care testing equipment. Under the banner of One ECB, he has implemented reforms to streamline the global business in a division with over 80% overseas sales. He has also transformed the business portfolio through M&A (including divestitures) and invested in solutions businesses, primarily at overseas bases.
- During his five-year term, he overcame the COVID-19 pandemic and transformed the eye care business from a low-growth structure to double-digit growth, achieving Hyper Growth from 2022 during his term. High growth will continue into 2024 after his retirement.
- In 2022, he established THINC (Topcon Healthcare INovation Center) in San Diego, USA, a base for promoting business through industry-academia collaboration. He built a strong team of all-Americans, with approximately half of the 40-plus members holding PhDs or MDs. In 2023, he established TH-INC (Topcon Healthcare Inc.) as a holding company for sales companies and software solutions companies. He was posted to San Diego as CEO to lead business development and realize a strategic partnership with Microsoft.
- With the launch of the new business coming to a close and his American successor fully trained, he will hand over the CEO role in April 2024 and return to Japan in June.
- On March 28, 2025, Topcon announced a management buyout (TOB) to take the company private, backed by KKR and JIC.
- On December 2, 2025, following the completion of the MBO by KKR and JIC, Topcon was delisted from the Tokyo Stock Exchange Prime Market.